Biological Markers of Alzheimer’s Disease

  • François Boller
  • Robert Katzman
  • André Rascol
  • Jean-Louis Signoret
  • Yves Christen
Conference proceedings

Part of the Research and Perspectives in Alzheimer’s Disease book series (ALZHEIMER)

Table of contents

  1. Front Matter
    Pages I-XV
  2. H. M. Wisniewski, P. D. Mehta, K. S. Kim, G. S. Merz
    Pages 23-29
  3. A. Delacourte, S. Flament, A. Défossez, L. Buee, B. Hémon, M. Parent et al.
    Pages 39-55
  4. J. W. Pettegrew
    Pages 83-104
  5. J. M. Salbaum, C. L. Masters, K. Beyreuther
    Pages 118-122
  6. F. de Sauvage, A. F. Macq, J. M. Maloteaux, J. N. Octave
    Pages 123-129
  7. R. E. Tanzi, P. St. George-Hyslop, M. James, J. L. Haines, J. F. Gusella
    Pages 130-137
  8. A. R. Haynes, M. J. Owen, A. M. Goate, L. A. James, M. J. Mullan, R. Williamson et al.
    Pages 138-145
  9. J. P. Blass, A. C. Baker, K.-F. R. Sheu, L. Ko, R. S. Black, A. Smith
    Pages 153-162
  10. S. Sorbi, M. Mortilla, S. Piacentini, G. Tesco, S. Tonini, L. Amaducci
    Pages 163-166
  11. Back Matter
    Pages 167-169

About these proceedings


This volume presents the proceedings of the symposium held in Toulouse on April 24, 1989, on the topic "Biological Markers of Alzheimer's Disease. " This sym­ posium was the fourth of a continuing and successful series of Colloques Medecine et Recherche organized by the Fondation IPSEN pour la Recherche Therapeutique, addressing various aspects of contemporary research in the field of Alzheimer's disease (AD). The series started in September 1987 with "Im­ munology and Alzheimer's Disease," followed 6 months later in Paris by "Gene­ tics and Alzheimer's Disease" and in September 1988 in Montpellier by "Neuronal Grafting and Alzheimer's Disease. " The present symposium was organized for the purpose of gathering the most current ideas concerning biological markers of AD. The papers presented at this symposium may be roughly subdivided into three groups. The first deals with the markers of AD at the level of the brain itself. These markers are studied either through the cerebrospinal fluid or through techniques such as nuclear magnetic resonance (NMR) - approaches which respectively aim at demonstrating the cerebral changes indicated by the debris resulting from the disease, or studying the possible neurochemical abnormalities that occur in the earlier stages of AD.


Alzheimer's disease Alzheimer-Krankheit Alzheimer´s disease biologische Marker blood brain cortex dementia diagnosis magnetic resonance nuclear magnetic resonance (NMR) pathogenesis patients research skin

Editors and affiliations

  • François Boller
    • 1
  • Robert Katzman
    • 2
  • André Rascol
    • 3
  • Jean-Louis Signoret
    • 4
  • Yves Christen
    • 5
  1. 1.Inserm U324ParisFrance
  2. 2.University of California at San DiegoLa JollaUSA
  3. 3.Hôpital PurpanToulouseFrance
  4. 4.Hôpital SalpêtrièreParisFrance
  5. 5.Fondation IPSEN pour la Recherche ThérapeutiqueParis CédexFrance

Bibliographic information

  • DOI
  • Copyright Information Springer-Verlag Berlin Heidelberg 1989
  • Publisher Name Springer, Berlin, Heidelberg
  • eBook Packages Springer Book Archive
  • Print ISBN 978-3-642-46692-2
  • Online ISBN 978-3-642-46690-8
  • Series Print ISSN 0945-6066
  • Buy this book on publisher's site
Industry Sectors
Health & Hospitals
Consumer Packaged Goods